13F filerCIK 1536411 ↗

Duquesne Family Office

You are looking at Q3 2017. See the latest, Q3 2026 →

Reported value

$2.20B

+18% on the quarter before

Positions

37

14 new, 11 sold out

Top 10

65.1%

of the value

Est. gain

+$113.7M

on stocks held all quarter

Est. return

+7.6%

on those stocks since Q2 2017

Filed

Nov 14, 2017

On SEC EDGAR ↗

Positions as of Sep 30, 2017, from Duquesne Family Office's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

Each tile is a position, sized by its share, colored by what the fund did with it since Q2 2017. Striped tiles are options.

Alphabet10%Microsoft9.8%
13 others9.1%
Meta8.4%Salesforce6.5%Amazon6.4%
Priceline Grp Inc6.2%
Alibaba6.1%
Electronic Arts Inc3.8%
Jd Com Inc3.8%
Workday3.8%
Citigroup Inc3.6%
Ctrip Com Intl Ltd3.4%
PayPal2.7%
Expedia Inc Del2.1%
Activision Blizzard Inc2.1%
Las Vegas Sands Corp1.8%
Ishares Tr1.7%
Chubb Limited1.3%
Nektar Therapeutics1.3%
Celgene Corp1.2%
Ac Immune Sa1.2%
Praxair Inc1.2%
Vale S A1.1%
Yum China Hldgs Inc1.1%

Largest buys

Since Q2 2017, sized at quarter-end prices.

  1. Citigroup Inc~$79.7MNew, 0.0% → 3.6% of the portfolio+1,095,200 shares
  2. Workday~$56.4MAdded, 1.3% → 3.8% of the portfolio+535,300 shares
  3. Alphabet~$55.7MAdded, 8.7% → 10.3% of the portfolio+57,200 shares
  4. Salesforce~$41.6MAdded, 5.0% → 6.5% of the portfolio+444,900 shares
  5. Jd Com Inc~$31.6MAdded, 2.9% → 3.8% of the portfolio+826,300 shares
  6. Chubb Limited~$29.5MNew, 0.0% → 1.3% of the portfolio+206,600 shares
  7. Celgene Corp~$27.4MNew, 0.0% → 1.2% of the portfolio+188,100 shares
  8. Praxair Inc~$25.8MNew, 0.0% → 1.2% of the portfolio+184,700 shares
  9. Vale S A~$25.0MNew, 0.0% → 1.1% of the portfolio+2,478,800 shares
  10. Amazon~$24.8MAdded, 6.2% → 6.4% of the portfolio+25,800 shares

Largest sells

Since Q2 2017, sized at quarter-end prices.

  1. Comcast Corp New~$76.6MSold out, 4.1% → 0.0% of the portfolio−1,968,400 shares
  2. Merck & Co Inc~$48.4MSold out, 2.6% → 0.0% of the portfolio−755,500 shares
  3. ServiceNow~$45.4MSold out, 2.4% → 0.0% of the portfolio−428,000 shares
  4. Autodesk~$35.1MSold out, 1.9% → 0.0% of the portfolio−347,800 shares
  5. Potash Corp Sask Inc~$28.5MCut, 1.8% → 0.5% of the portfolio−1,483,600 shares
  6. Netease Inc~$25.8MSold out, 1.4% → 0.0% of the portfolio−85,700 shares
  7. PTC~$24.8MSold out, 1.3% → 0.0% of the portfolio−449,600 shares
  8. Delta Air Lines Inc Del~$21.0MSold out, 1.1% → 0.0% of the portfolio−391,000 shares
  9. American Airls Group Inc~$20.1MSold out, 1.1% → 0.0% of the portfolio−400,000 shares
  10. United Contl Hldgs Inc~$18.3MSold out, 1.0% → 0.0% of the portfolio−243,500 shares

Holdings

As of Sep 30, 2017; changes in shares since Jun 30, 2017.

Positions, sorted by share of the portfolio
HoldingValue
AlphabetCAP STK CL A · shares +33% · price +4.7%10.3%$225.8M+$7.7M
MicrosoftCOM · shares +10% · price +8.1%9.8%$216.5M+$14.6M
MetaCL A · shares 0% · price +13.2%8.4%$185.2M+$21.6M
SalesforceCOM · shares +41% · price +7.9%6.5%$142.6M+$7.4M
AmazonCOM · shares +21% · price −0.7%6.4%$140.2M−$797,881
Priceline Grp IncCOM NEW · shares +18% · price −2.1%6.2%$135.6M−$2.5M
AlibabaSPONSORED ADS · shares +9.5% · price +22.6%6.1%$134.3M+$22.6M
Electronic Arts IncCOM · shares 0% · price +11.7%3.8%$84.3M+$8.8M
Jd Com IncSPON ADR CL A · shares +61% · price −2.6%3.8%$83.5M−$1.4M
WorkdayCL A · shares +214% · price +8.6%3.8%$82.8M+$2.1M
Citigroup IncCOM NEW · shares New3.6%$79.7M—
Ctrip Com Intl LtdAMERICAN DEP SHS · shares 0% · price −2.1%3.4%$74.5M−$1.6M
PayPalCOM · shares 0% · price +19.3%2.7%$59.2M+$9.6M
Expedia Inc DelCOM NEW · shares 0% · price −3.4%2.1%$46.6M−$1.6M
Activision Blizzard IncCOM · shares 0% · price +12.1%2.1%$46.1M+$5.0M
Las Vegas Sands CorpCOM · shares 0% · price +0.4%1.8%$39.4M+$166,000
Ishares TrNASDAQ BIOTECH · shares +34% · price +7.5%1.7%$36.9M+$1.9M
Chubb LimitedCOM · shares New1.3%$29.5M—
Nektar TherapeuticsCOM · shares 0% · price +22.8%1.3%$28.0M+$5.2M
Celgene CorpCOM · shares New1.2%$27.4M—
Ac Immune SaSHS · shares 0% · price +28.4%1.2%$27.0M+$6.0M
Praxair IncCOM · shares New1.2%$25.8M—
Vale S AADR · shares New1.1%$25.0M—
Yum China Hldgs IncCOM · shares 0% · price +1.4%1.1%$23.9M+$322,000
MastercardCL A · shares 0% · price +16.3%1.1%$23.3M+$3.3M
Total 37 positions100%$2.20B+$113.7M

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q2 2017 to Q3 2017: 23 stocks held throughout, up $113.7M (+7.6%).

  1. Alibaba+$22.6M+23%
  2. Meta+$21.6M+13%
  3. Microsoft+$14.6M+8%
  4. PayPal+$9.6M+19%
  5. Electronic Arts Inc+$8.8M+12%
  6. Amazon−$797,881−1%
  7. Jd Com Inc−$1.4M−3%
  8. Ctrip Com Intl Ltd−$1.6M−2%
  9. Expedia Inc Del−$1.6M−3%
  10. Priceline Grp Inc−$2.5M−2%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

Pick a quarter to see what the fund held then.

$6.00B$3.00B$0
Q1 2016Q3 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q3 2026$4.47B−14%SEC ↗
Q2 2026$5.21B+54%SEC ↗
Q1 2026$3.38B−25%SEC ↗
Q4 2025$4.49B+11%SEC ↗
Q3 2025$4.06B−0%SEC ↗
Q2 2025$4.07B+33%SEC ↗
Q1 2025$3.06B−18%SEC ↗
Q4 2024$3.72B+26%SEC ↗
Q3 2024$2.95B+1%SEC ↗
Q2 2024$2.92B−34%SEC ↗
Q1 2024$4.39B+31%SEC ↗
Q4 2023$3.35B+20%SEC ↗
Q3 2023$2.79B−3%SEC ↗
Q2 2023$2.87B+25%SEC ↗
Q1 2023$2.31B+14%SEC ↗
Q4 2022$2.02B+15%SEC ↗
Q3 2022$1.76B+28%SEC ↗
Q2 2022$1.38B−40%SEC ↗
Q1 2022$2.31B−16%SEC ↗
Q4 2021$2.76B−10%SEC ↗
Q3 2021$3.08B−24%SEC ↗
Q2 2021$4.04B−11%SEC ↗
Q1 2021$4.53B+22%SEC ↗
Q4 2020$3.71B+8%SEC ↗
Q3 2020$3.44B+5%SEC ↗
Q2 2020$3.27B+32%SEC ↗
Q1 2020$2.47B−28%SEC ↗
Q4 2019$3.41B+33%SEC ↗
Q3 2019$2.57B−24%SEC ↗
Q2 2019$3.37B−2%SEC ↗
Q1 2019$3.45B+100%SEC ↗
Q4 2018$1.73B−18%SEC ↗
Q3 2018$2.10B+2%SEC ↗
Q2 2018$2.07B+14%SEC ↗
Q1 2018$1.81B−9%SEC ↗
Q4 2017$1.98B−10%SEC ↗
Q3 2017$2.20B+18%SEC ↗
Q2 2017$1.87B+22%SEC ↗
Q1 2017$1.52B+49%SEC ↗
Q4 2016$1.03B−9%SEC ↗
Q3 2016$1.13B+30%SEC ↗
Q2 2016$870.7M−35%SEC ↗
Q1 2016$1.34BSEC ↗

Subscribe to TheInference for free